Related Experiment Videos
[Anti-hypertensive action of Captopril. Hemodynamic study (author's transl)]
Insights
SQ 14 225, an orally active converting enzyme inhibitor, reduced blood pressure and peripheral resistance in hypertensive patients. Its vasodilatory effect was demonstrated, questioning the renin-angiotensin system's role in blood pressure reduction.
Area of Science:
- Cardiovascular Pharmacology
- Hypertension Research
- Pharmacodynamics
Context:
- Essential hypertension affects millions globally, necessitating effective therapeutic strategies.
- Converting enzyme inhibitors represent a key class of antihypertensive medications.
- Understanding the precise mechanisms of drug action is crucial for optimizing treatment.
Purpose:
- To investigate the hemodynamic effects of SQ 14 225, a novel converting enzyme inhibitor.
- To assess the impact of SQ 14 225 on blood pressure, peripheral resistance, cardiac output, and heart rate in hypertensive patients.
- To explore the relationship between baseline plasma renin activity and the blood pressure response to SQ 14 225.
Summary:
- Hemodynamic parameters were evaluated in 6 patients with sustained essential hypertension before and after oral administration of SQ 14 225.
- A significant reduction in blood pressure and total peripheral resistance was observed, while cardiac output and heart rate remained unchanged.
- No correlation was found between basal plasma renin activity and the observed decrease in blood pressure, suggesting a potential mechanism independent of the renin-angiotensin system.
Impact:
- The study highlights the vasodilatory properties of SQ 14 225.
- Findings challenge the exclusive role of the renin-angiotensin system in mediating the blood pressure-lowering effects of this agent.
- Provides insights into the pharmacological profile of converting enzyme inhibitors for hypertension management.
Abstract:
Hemodynamic parameters were studied before and after administration of SQ 14 225, an orally active converting enzyme inhibitor, in 6 sustained essential hypertensive patients. Blood pressure and total peripheral resistance significantly decreased while cardiac output and heart rate remained unchanged. Systolic time intervals and plasma volume were not modified. No correlation was observed between the basal value of plasma renin activity and the decrease in blood pressure. The study demonstrated the vasodilatator effect of SQ 14 225 and questionned the role of the renin-angiotensin system in the mechanism of the pressure decrease.